Document is current
Any future updates will be listed below
-
Authors
Parkes, Eileen E. https://orcid.org/0000-0002-7855-3698
Savage, Kienan I. https://orcid.org/0000-0002-4898-899X
Lioe, Tong
Boyd, Clinton
Halliday, Sophia
Walker, Steven M.
Lowry, Keith
Knight, Laura
Buckley, Niamh E. https://orcid.org/0000-0001-9326-8513
Grogan, Andrena
Logan, Gemma E.
Clayton, Alison
Hurwitz, Jane
Kirk, Stephen J.
Xu, Jiamei
Sidi, Fatima Abdullahi https://orcid.org/0000-0003-0205-4486
Humphries, Matthew P.
Bingham, Victoria
,
Ang, Melvyn
Askin, Conal
Bamford, Louise
Boyd, Ruth
Buckley, Miriam
Clarke, Jacqueline
Darragh, Lynn
Davis, Elaine
Foreman, Jennifer
Gallagher, Rebecca
Gill, Janine
Hanna, Michael
Hill, Naomi
Irwin, Gareth
Mallon, Peter
McAleer, Seamus
McAllister, Joanne
Morris, Melanie
Pierce, Nicole
Refsum, Sigi
Sloan, Samantha
Treanor, Sinead
James, Jaqueline A.
James, Colin R.
Paul Harkin, D.
Kennedy, Richard D. https://orcid.org/0000-0003-4737-6163
McIntosh, Stuart A. https://orcid.org/0000-0002-4123-9611
-
Funding
Funding for this research was provided by:
Cancer Research UK (C44582/A29302, C44582/A29302)
- License Information
-
More Information
Article History
Received: 8 February 2021
Revised: 21 September 2021
Accepted: 11 October 2021
First Online: 2 November 2021
Competing interests
: SMW, LK, AMcC, GEL, DPH and RDK are employees of Almac Diagnostic Services. SMW, LK, DOH, EEP and RDH hold associated patents on file, ‘Molecular Diagnostic Test for Cancer’ and ‘Gene Signature for Immune Therapies in Cancer’. KIS is a consultant for Almac Diagnostic Services. SMcI, TL, CB, SH, KL, AC, JH, NEB, JAJ, JX, VB, FAS, MH and SJK declare no competing interests.
: Ethical approval was obtained from the Office for Research Ethics Northern Ireland (Reference: 13/NI/0107). All patients provided written informed consent for participation.
: Not applicable.
